Biotech Firm Secures Patent for Regenerative Breast Implants and Injectable Fillers
The European patent covers a plant-based collagen technology designed to support natural tissue regeneration in both aesthetic and reconstructive procedures.
The European patent covers a plant-based collagen technology designed to support natural tissue regeneration in both aesthetic and reconstructive procedures.
The injectable, known as Restylane Contour in the US, achieved a 94.4% responder rate at six months, with improvements sustained through 12 months.